Therapeuticsmd Inc (TXMD)

May 13, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

May 13, 2026

May 13, 2026

TherapeuticsMD Announces First Quarter 2026 Financial Results - BioSpace

May 13, 2026

May 13, 2026

TXMD Reports Strong Q1 Revenue Growth and Explores Strategic Alt - GuruFocus

May 13, 2026

May 12, 2026

Is TherapeuticsMD (TXMD) 13.4% Overvalued After Q1 2026 Earnings - GuruFocus

May 12, 2026

May 12, 2026

[10-Q] TherapeuticsMD, Inc. Quarterly Earnings Report - Stock Titan

May 12, 2026

May 12, 2026

TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives - TipRanks

May 12, 2026

May 12, 2026

TherapeuticsMD: Q1 Earnings Snapshot - marketscreener.com

May 12, 2026

May 12, 2026

TherapeuticsMD swings to Q1 net income as license revenue rises - TradingView

May 12, 2026

May 12, 2026

TherapeuticsMD (TXMD) details Q1 2026 results and strategic review - Stock Titan

May 12, 2026

May 11, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

May 11, 2026

May 08, 2026

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

May 08, 2026

May 06, 2026

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 06, 2026

May 01, 2026

TXMD Stock Price, Quote & Chart | THERAPEUTICSMD INC (NASDAQ:TXMD) - ChartMill

May 01, 2026

Apr 30, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 30, 2026

Apr 24, 2026

TXMD Should I Buy - Intellectia AI

Apr 24, 2026

Apr 23, 2026

TXMD (TherapeuticsMD Inc.) posts far wider Q3 2023 loss than expected, with shares dipping 0.48% in today’s trading.Stock Community Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 22, 2026

TXMD (TherapeuticsMD Inc.) Q3 2023 EPS misses consensus estimates by wide margin as shares dip 0.48 percent in today's trading.Trending Stock Ideas - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 11, 2026

Form 10-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]: [Amend] - ADVFN

Apr 11, 2026

Apr 09, 2026

Total debt per share of TherapeuticsMD, Inc. – MUN:29TA - TradingView — Track All Markets

Apr 09, 2026

Apr 08, 2026

TherapeuticsMD Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 08, 2026

Apr 07, 2026

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Apr 07, 2026

Apr 06, 2026

[SCHEDULE 13G] TherapeuticsMD, Inc. Passive Investment Disclosure (>5%) - Stock Titan

Apr 06, 2026

Apr 06, 2026

Profit Recap: Is TherapeuticsMD Inc stock a buy or sell2026 Review & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Apr 06, 2026

Apr 02, 2026

TherapeuticsMD Inc. (TXMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Apr 02, 2026

Apr 02, 2026

TherapeuticsMD Inc. R (29TA.F) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

TherapeuticsMD Explains Brief Delay In Annual Filing - The Globe and Mail

Apr 02, 2026

Apr 01, 2026

TherapeuticsMD 2025 Annual Report: Business Overview, Risk Factors, and Intellectual Property Challenges - Minichart

Apr 01, 2026

Apr 01, 2026

[10-K/A] TherapeuticsMD, Inc. Amends Annual Report - Stock Titan

Apr 01, 2026

Mar 31, 2026

TherapeuticsMD Inc. stock rises Tuesday, still underperforms market - MarketWatch

Mar 31, 2026

Mar 31, 2026

TherapeuticsMD, Inc. (TXMD) stock price, news, quote and history - Yahoo Finance UK

Mar 31, 2026

Mar 31, 2026

TherapeuticsMD Announces Full Year 2025 Financial Results - BioSpace

Mar 31, 2026

Mar 31, 2026

TherapeuticsMD (NASDAQ: TXMD) files 2025 Form 10-K after printer error - Stock Titan

Mar 31, 2026

Mar 30, 2026

TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy - TipRanks

Mar 30, 2026

Mar 30, 2026

TXMD Reports $7.5 Million in Cash Holdings as of Year-End 2025 - GuruFocus

Mar 30, 2026

Mar 30, 2026

TXMD: Net loss narrowed and license revenue surged as strategic alternatives are explored - TradingView

Mar 30, 2026

Mar 30, 2026

TXMD: 2025 saw improved results from royalty revenue, but litigation and liquidity risks threaten viability - TradingView — Track All Markets

Mar 30, 2026

Mar 30, 2026

TherapeuticsMD (NASDAQ: TXMD) reports 2025 results, weighs strategic options - Stock Titan

Mar 30, 2026

Mar 30, 2026

[10-K] TherapeuticsMD, Inc. Files Annual Report - Stock Titan

Mar 30, 2026

Mar 30, 2026

TXMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 30, 2026

Mar 29, 2026

TherapeuticsMD, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Mar 29, 2026